Author: Elekhnawy, Engy; Kamar, Amal Abo; Sonbol, Fatma
Title: Present and future treatment strategies for coronavirus disease 2019 Cord-id: cu30xyyz Document date: 2021_4_9
ID: cu30xyyz
Snippet: BACKGROUND: The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in many challenges to the healthcare organizations around the world. Unfortunately, until now, there are no proven effective therapeutic agents against this virus. MAIN BODY: Several evolving studies suggest repurposing a potential list of drugs which have appropriate pharmacological and therapeutic effects to be used in treating COVID-19 cases. In the present review, we will summarize the potential drugs suggest
Document: BACKGROUND: The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in many challenges to the healthcare organizations around the world. Unfortunately, until now, there are no proven effective therapeutic agents against this virus. MAIN BODY: Several evolving studies suggest repurposing a potential list of drugs which have appropriate pharmacological and therapeutic effects to be used in treating COVID-19 cases. In the present review, we will summarize the potential drugs suggested to be repurposed to be utilized in the treatment of COVID-19 patients like lopinavir-ritonavir, ribavirin, baloxavir marboxil, favipiravir, remdesvir, umifenovir, chloroquine, hydroxychloroquine, azithromycin, corticosteroids, losartan, statins, interferons, nitric oxide, epoprostenol, tocilizumab, siltuximab, sarilumab anakinra, and ruxolitinib. In addition, we discussed the possible future therapeutic regimens based on the recent molecular and genomic discoveries. CONCLUSION: This review could provide beneficial information about the potential current and future treatment strategies to treat the pandemic COVID-19 disease.
Search related documents:
Co phrase search for related documents- ace inhibitor and acute lung injury: 1, 2, 3, 4
- ace inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- ace inhibitor and adaptive immunity: 1
- active form and acute ards respiratory distress syndrome: 1
- active form and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- active form and adaptive immunity: 1, 2
- active form and adenosine analogue: 1, 2, 3
- acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and additional benefit: 1, 2
- acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
- acute lung injury and additional investigation: 1
- acute sars cov respiratory syndrome coronavirus and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and additional benefit: 1, 2, 3, 4
- acute sars cov respiratory syndrome coronavirus and additional investigation: 1, 2, 3, 4, 5, 6, 7
- acute sars cov respiratory syndrome coronavirus and adenosine analogue: 1, 2, 3
- acute viral infection and adaptive immunity: 1, 2
Co phrase search for related documents, hyperlinks ordered by date